{{Rsnum
|rsid=2834215
|Gene=IFNGR2
|Chromosome=21
|position=33424579
|Orientation=plus
|GMAF=0.3825
|Gene_s=IFNGR2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 23.0 | 49.6 | 27.4
| HCB | 75.2 | 23.4 | 1.5
| JPT | 58.0 | 36.6 | 5.4
| YRI | 56.5 | 38.1 | 5.4
| ASW | 45.6 | 43.9 | 10.5
| CHB | 75.2 | 23.4 | 1.5
| CHD | 74.3 | 24.8 | 0.9
| GIH | 36.6 | 44.6 | 18.8
| LWK | 42.7 | 43.6 | 13.6
| MEX | 43.1 | 37.9 | 19.0
| MKK | 20.0 | 56.8 | 23.2
| TSI | 21.6 | 37.3 | 41.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22936669
  |Trait=Crohn's disease
  |Title=A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300.
  |RiskAllele=
  |Pval=3E-7
  |OR=1.22
  |ORtxt=[1.12-1.32]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}